These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25991924)

  • 21. A prediction of the CRNDE role by modulating NF-κB pathway in inflammatory bowel disease (IBD).
    Kazemifard N; Farmani M; Baradaran Ghavami S; Kazemi M; Shahrokh S; Asadzadeh Aghdaei H; Zali M
    Biochem Biophys Rep; 2024 Jul; 38():101731. PubMed ID: 38766384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.
    Costello CM; Mah N; Häsler R; Rosenstiel P; Waetzig GH; Hahn A; Lu T; Gurbuz Y; Nikolaus S; Albrecht M; Hampe J; Lucius R; Klöppel G; Eickhoff H; Lehrach H; Lengauer T; Schreiber S
    PLoS Med; 2005 Aug; 2(8):e199. PubMed ID: 16107186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative analysis of transcriptome-wide association study data and messenger RNA expression profiles identified candidate genes and pathways for inflammatory bowel disease.
    Cheng B; Liang X; Wen Y; Li P; Zhang L; Ma M; Cheng S; Du Y; Liu L; Ding M; Zhao Y; Zhang F
    J Cell Biochem; 2019 Sep; 120(9):14831-14837. PubMed ID: 31009124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD.
    Schulze HA; Häsler R; Mah N; Lu T; Nikolaus S; Costello CM; Schreiber S
    Genes Immun; 2008 Apr; 9(3):240-8. PubMed ID: 18340362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
    Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis and characterization of long non-coding RNA genes in inflammatory bowel disease.
    Velissari R; Ilieva M; Dao J; Miller HE; Madsen JH; Gorodkin J; Aikawa M; Ishii H; Uchida S
    Brief Funct Genomics; 2024 Jul; 23(4):395-405. PubMed ID: 37791426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
    Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
    Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
    Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.
    Ellinghaus D; Bethune J; Petersen BS; Franke A
    Scand J Gastroenterol; 2015 Jan; 50(1):13-23. PubMed ID: 25523552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients.
    Huang X; Hao C; Bao H; Wang M; Dai H
    J Assist Reprod Genet; 2016 Jan; 33(1):111-21. PubMed ID: 26650608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients.
    Sideri A; Bakirtzi K; Shih DQ; Koon HW; Fleshner P; Arsenescu R; Arsenescu V; Turner JR; Karagiannides I; Pothoulakis C
    Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):420-432. PubMed ID: 26543894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.